Philippe Pouletty

Co-Founder & CEO

Truffle Capital

Joined: 2001

Office Phone:

+33 1 82 28 46 00


  Pro - Try 1 Week Free
 

    and access,

  •     80K PE/M&A Contacts
  •     +
  •     4.6K PE Firms
  •     3.6K M&A Advisors
  •     198K Transactions
  •     202K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Philippe has a strong background in Europe and the United States (including Silicon Valley) and is a pioneer in the biotechnology and medical devices sector. Entrepreneur, he is the Founder and Co-Founder of Truffle companies developing high technologies, including Abivax, Carbios, Vexim, Carmat, Symetis, Affluent Medical, Diaccurate & Caranx Medical. As an inventor, Philippe has filed 32 patents, one of which is the second-highest revenue generator in life sciences for Stanford University, earning him membership in Stanford’s prestigious Invention Hall of Fame in 2012. Philippe was Chairman of France Biotech, from 2001 to 2009, and has held the title of Honorary Chairman since 2009. He conceived the « Jeune Entreprise Innovante » (JEI) program to boost the development of young and innovative company in France. Philippe Pouletty is a medical doctor, former resident in haematology and immunology in Parisian hospitals, and was a post-doctoral researcher (1986-1988) at Stanford University. The 1999 winner of the American Liver Foundation. Dr. Philippe Pouletty has been awarded « Chevalier de la Légion d’Honneur ».

Education

Work History

Deinove SA

Abivax